查看购物车
  • Traditional Chinese
  • Japanese
  • Korean
女性健康诊断市场－全球展望与2030年预测
市场调查报告书
商品编码
1771762

女性健康诊断市场－全球展望与2030年预测

Women's Health Diagnostic Markets: Global Outlook and Forecast to 2030
出版日期: | 出版商: Kalorama Information | 英文 210 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

《女性健康诊断市场－全球展望与2030年预测》提供全面的资料驱动分析，涵盖临床、即时诊断（POC）和非处方（OTC）领域，涵盖女性健康诊断检测的全球格局。随着全球人口结构的变化以及女性寿命的延长，医疗保健系统必须认识并解决疾病风险、筛检和治疗方面的性别差异。诊断是这一转变的核心，能够在女性的整个生命週期中提供个人化和及时的干预措施。

本详细报告预测了2030年全球诊断检测和诊断系统的市场趋势，并对与女性健康相关的各种诊断类别进行了区域细分和趋势分析。本研究涵盖了用于检测、筛检和监测女性特有疾病或在女性中高度流行的疾病的现有技术和新兴技术。市场规模反映产品和系统的销售，包括设备安装和软体支援等相关服务。

本报告涵盖的主要诊断领域包括：

  • 乳房和生殖健康影像：乳房X光检查、CADe/CADx、产科超音波、乳房超音波成像
  • 产前检测和带因者筛检：非侵入性产前检测（NIPT）、带因者筛检、母胎诊断
  • 传染病和性传染病：HPV 诊断、TORCH 免疫测定、分子泌尿道感染（UTI）检测
  • 不孕症与怀孕检验：排卵、排卵荷尔蒙的实验室和即时检测、怀孕状态
  • 癌症与慢性病监测：巴氏抹片检查、卵巢癌生物标记、女性特异性自体免疫免疫测定
  • 骨骼健康与预防诊断：骨密度检测与早期癌症检测的阴道镜系统

每一章都探讨了推动每个类别成长的科学基础和技术创新，并应对了监管变化、偿付、市场准入和产品差异化等挑战。本报告基于对行业专家的访谈、临床实验室的意见以及广泛的一手和二手研究，提供市场预测和趋势评估。

每个类别都介绍了各种的诊断公司，从主导的跨国公司到灵活的利基市场参与者。这些公司包括BD、GE Healthcare、Hologic、Roche、Siemens Healthineers、Thermo Fisher等。这些公司正透过生物标记、自动化、数位成像、家用检测等领域的创新，积极塑造女性诊断的未来。

鑑于诊断测试目前驱动着超过 70%的医疗决策，本报告不仅将女性健康诊断定位为一个不断成长的市场，而且还将其定位为精准医疗的关键组成部分。本报告所包含的见解对于致力于扩大获取途径、改善临床结果以及投资符合女性不断变化的健康需求的下一代诊断解决方案的利益相关者非常重要。

目录

关于研究公司

第1章 执行摘要

第2章 引言

  • 女性健康：进步空间
  • 女性健康视角
  • 某些疾病在女性和男性的发展方式不同
    • 疼痛
    • 心臟
    • 大脑
    • 情绪
    • 骨骼结构
    • 酒精
    • 药物副作用
    • 吸烟
    • 生育能力
    • 性传染病与爱滋病毒
    • 自体免疫疾病
    • 癌症
    • 女性较常见的癌症
    • 肌肉骨骼健康
    • 出生缺陷
    • 泌尿道感染泌尿道感染（UTI）
  • 女性健康筛检的主要趋势与挑战
    • 卵巢癌诊断与生物标记
    • HPV 检测
    • 更广泛的带因者筛检和非侵入性产前检测（NIPT）
    • 泌尿道感染的多重与分子检测
    • 影像学与人工智慧
    • 怀孕和排卵
    • 自体免疫检测

第3章 乳房 X 光摄影

  • 简介
  • 乳房 X 光摄影市场
  • 电脑辅助侦测/诊断（CADe/CADx）
  • 乳房成像中的人工智慧引进
  • 监理变化
  • 竞争格局
    • Fujifilm Holdings Corp.
    • GE HealthCare
    • Hologic
    • Siemens Healthineers

第4章 超音波

  • 简介
  • 妇产科
  • 乳房成像
  • 市场趋势
  • 妇产科超音波趋势
  • 乳房影像市场
  • 竞争格局
    • GE HealthCare
    • Hologic
    • Philips
    • Siemens Healthineers

第5章 产前和带因者筛检

  • 简介
  • 非侵入性产前检测（NIPT）
  • 遗传学的进步带来新的挑战
  • 携带者筛检
  • 检测采用趋势
  • 遗传性疾病
  • 併购与合作
  • 非侵入性产前检测（NIPT）和带因者筛检市场
  • 竞争格局
    • Agilent
    • Illumina
    • Qiagen
    • Revvity
    • Thermo Fisher Scientific

第6章 HPV 检测

  • 简介
  • 概述
  • HPV 体外诊断检测市场
  • HPV 检测与全球筛检项目
  • 竞争格局
    • BD (Becton, Dickinson and Company)
    • Hologic
    • QIAGEN
    • Roche

第7章 妊娠与排卵

  • 简介
  • 侦测视角
  • 数位化检测
  • 实验室检测
  • 趋势
  • 市场
  • 产品
  • TORCH检测
  • 竞争格局
    • 市场参与者
    • NowDiagnostics Inc.
    • Salignostics
    • Sekisui
    • Acon
    • 主要公司
    • Abbott
    • Beckman Coulter (Danaher)
    • bioMerieux
    • Church & Dwight
    • Roche
    • Siemens Healthineers

第8章 巴氏抹片检测

  • 简介
  • 子宫颈癌检测
  • 趋势
  • 巴氏抹片检测市场
  • 竞争格局
    • BD (Becton Dickinson)
    • Hologic

第9章 自体免疫疾病疾病

  • 引言
  • 遗传因素
  • 对女性患者的影响
  • 近期趋势
  • 女性自体免疫疾病实验室免疫测定市场
  • 竞争格局
    • Bio-Rad
    • Euroimmun（Revvity）
    • Thermo Fisher Scientific

第10章 骨密度检测

  • 引言
  • 骨质疏鬆症发生率惊人成长
  • 推动骨密度测量需求
  • 双能量X光骨密度仪（DEXA）及竞争技术趋势
  • 骨密度检测市场
  • 竞争格局
    • DMS Imaging (European Medical Solutions)
    • GE HealthCare
    • Hologic

第11章 阴道镜检查

  • 简介
  • 子宫颈癌筛检与诊断
  • 趋势
  • 阴道镜系统市场
  • 竞争格局
    • Apgar Danmark A/S
    • CooperSurgical
    • Olympus

第12章 泌尿道感染

  • 简介
  • 发病率和死亡率的主要原因
  • 影响
  • 趋势
  • 技术进步超越临床指南
  • 次世代定序（NGS）
  • 多重PCR、qPCR
  • 尿路感染分子检测市场
  • 竞争格局
    • 中小企业机会
    • 公司亮点
    • BioGX
    • Camtech
    • PathogenDx
    • Randox Laboratories
    • RayBiotech
    • Thermo Fisher Scientific

第13章 卵巢癌

  • 简介
  • 卵巢癌的类型
  • CA-125
  • 趋势
  • 多变量指数分析与基因组检测
  • 卵巢癌生物标记市场
  • 竞争格局
    • 公司亮点
    • Abbott
    • Fujirebio
    • Illumina
    • Roche
    • Thermo Fisher Scientific
简介目录
Product Code: 25-072KA

Kalorama Information's "Women's Health Diagnostic Markets: Global Outlook and Forecast to 2030" offers a comprehensive, data-driven analysis of the global landscape for diagnostic tests that specifically address women's health across clinical, point-of-care (POC), and over-the-counter (OTC) settings. As global demographics shift-with women living longer than men-healthcare systems are under increasing pressure to recognize and address sex-based differences in disease risk, screening, and treatment. Diagnostics are at the core of this transformation, offering the ability to deliver personalized and timely interventions across a woman's life span.

This in-depth report forecasts global market revenues for diagnostic tests and systems through 2030, providing regional segmentation and trend analysis across a broad spectrum of diagnostic categories relevant to female health. The study encompasses both established and emerging technologies used in the detection, screening, and monitoring of conditions unique to, or highly prevalent among, women. Market sizing reflects product and system sales, including associated services such as instrument installation and software support.

Key diagnostic sectors covered in the report include:

  • Breast and Reproductive Health Imaging: Mammography, CADe/CADx, OB/GYN ultrasound, and breast ultrasound imaging.
  • Prenatal and Carrier Screening: Non-invasive prenatal testing (NIPT), carrier screening, and maternal-fetal diagnostics.
  • Infectious and Sexually Transmitted Diseases: HPV diagnostics, TORCH immunoassays, and molecular urinary tract infection (UTI) testing.
  • Fertility and Pregnancy Testing: Lab-based and POC tests for ovulation, fertility hormones, and pregnancy status.
  • Cancer and Chronic Disease Monitoring: Pap tests, ovarian cancer biomarkers, and female-specific autoimmune immunoassays.
  • Bone Health and Preventive Diagnostics: Bone densitometry testing and colposcopy systems for early cancer detection.

Each chapter explores the scientific foundations and technological innovations driving growth in its respective category while addressing challenges such as regulatory shifts, reimbursement, market access, and product differentiation. The report draws on interviews with industry experts, input from clinical labs, and extensive primary and secondary research to inform market forecasts and trend assessments.

A diverse group of diagnostic players-ranging from dominant multinationals to nimble niche firms-are profiled in each category. Companies covered include BD, GE Healthcare, Hologic, Roche, Siemens Healthineers, and Thermo Fisher, among others. These firms are actively shaping the future of women's diagnostics through innovation in biomarkers, automation, digital imaging, and home-based testing.

At a time when diagnostic testing influences more than 70% of medical decisions, this report positions women's health diagnostics not only as a growing market but also as a critical component of precision medicine. The insights contained herein are essential for stakeholders focused on expanding access, improving clinical outcomes, and investing in the next generation of diagnostic solutions tailored to women's evolving health needs.

Table of Contents

About Kalorama Information

Chapter 1: Executive Summary

  • Overview
  • Scope and Methodology
  • Market Overview and Potential
    • Figure 1-1: World Markets for Key Women's Health Diagnostics, by Product Segment, 2024-2030 ($ million) [Autoimmune immunoassay, Bone densitometry, CADe/CADx, Colposcopy systems, Female HPV IVD tests, Lab based fertility immunoassay, Lab based TORCH immunoassay, Mammography, Molec. prenatal, carrier, NIPT, Molecular UTI tests for females, Ovarian cancer immunoassays, Pap tests, POC pregnancy & fertility, Ultrasound breast imaging, Ultrasound OB/GYN]
    • Table 1-1: World Markets for Key Women's Health Diagnostics, by Product Segment, 2024-2030 ($ million) [Autoimmune immunoassay, Bone densitometry, CADe/CADx, Colposcopy systems, Female HPV IVD tests, Lab based fertility immunoassay, Lab based TORCH immunoassay, Mammography, Molec. prenatal, carrier, NIPT, Molecular UTI tests for females, Ovarian cancer immunoassays, Pap tests, POC pregnancy & fertility, Ultrasound breast imaging, Ultrasound OB/GYN]

Chapter 2: Introduction

  • Female Health: Room for Improvement
  • Perspective on Women's Health
  • Women and Men Develop Some Diseases Differently
    • Pain
    • The Heart
    • The Brain
    • Emotions
    • Bone Structure
    • Alcohol
    • Drug Side Effects
    • Smoking
    • Fertility
    • STIs and HIV
    • Autoimmune Disease
    • Cancer
    • Leading Female Cancers
    • Musculoskeletal Health
    • Congenital Abnormalities
    • Urinary Tract Infections (UTIs)
  • Key Trends and Issues in Women's Health Diagnostics
    • Ovarian Cancer Diagnostics and Biomarkers
    • HPV Testing
    • Broader Carrier Screening and NIPT
    • Multiplex and Molecular Testing for UTIs
    • Imaging and AI
    • Pregnancy and Ovulation
    • Autoimmune Laboratory Immunoassays

Chapter 3: Mammography

  • Introduction
    • Transition to Digital
    • Economics of Routine Screening
    • Digital Breast Tomosynthesis (DBT or 3D Mammography)
  • Mammography Market
    • Table 3-1: World Mammography Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 3-1: World Mammography Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 3-2: World Mammography Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 3-3: World Mammography Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Computer-Aided Detection/Diagnosis (CADe/CADx)
    • Table 3-2: World CADe/CADx Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 3-4: World CADe/CADx Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 3-5: World CADe/CADx Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 3-6: World CADe/CADx Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Artificial Intelligence Adoption in Breast Imaging
    • Key Trends in AI-Driven CAD
    • Trends
  • Regulatory Changes
  • Competitive Landscape
    • Fujifilm Holdings Corp.
    • GE HealthCare
    • Hologic
    • Siemens Healthineers

Chapter 4: Ultrasound

  • Introduction
    • Table 4-1: Key Applications for Medical Ultrasound
  • Obstetrics and Gynecology
  • Breast Imaging
  • Market Trends
  • Obstetric and Gynecological Ultrasound Trends
    • Table 4-2: World Ultrasound OB/GYN Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 4-1: World Ultrasound OB/GYN Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 4-2: World Ultrasound OB/GYN Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 4-3: World Ultrasound OB/GYN Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Breast Imaging Market
    • Table 4-3: World Ultrasound Breast Imaging Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 4-4: World Ultrasound Breast Imaging Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 4-5: World Ultrasound Breast Imaging Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 4-6: World Ultrasound Breast Imaging Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • GE HealthCare
    • Hologic
    • Philips
    • Siemens Healthineers

Chapter 5: Prenatal and Carrier Screening

  • Introduction
  • NIPT
  • Advances in Genetics Bring New Challenges
  • Carrier Screening
  • Test Adoption Trends
  • Inherited Diseases
    • Inflammatory Bowel Disease (IBD) and Crohn's Disease
    • Autism Spectrum Disorder (ASD)
    • Alzheimer's Disease (AD)
    • Cardiovascular Disease (CVD)
    • Psychiatric Disorders
  • M&A, Partnerships
  • NIPT and Carrier Screening Markets
    • Table 5-1: World Prenatal and Carrier Test, NIPT Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 5-1: World Prenatal and Carrier Test, NIPT Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 5-2: World Prenatal and Carrier Test, NIPT Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 5-3: World Prenatal and Carrier Test, NIPT Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Agilent
    • Illumina
    • Qiagen
    • Revvity
    • Thermo Fisher Scientific

Chapter 6: HPV Testing

  • Introduction
  • Overview
    • HPV Infection
    • Infection in Females
    • High-Risk Types and Cervical Cancer
    • HPV Testing
  • HPV IVD Test Market
    • Table 6-1: World Female HPV IVD Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 6-1: World Female HPV IVD Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 6-2: World Female HPV IVD Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 6-3: World Female HPV IVD Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • HPV Testing and Global Screening Programs
  • Competitive Landscape
    • BD (Becton, Dickinson and Company)
    • Hologic
    • QIAGEN
    • Roche

Chapter 7: Pregnancy and Ovulation

  • Introduction
  • Perspective on Testing
  • Digital Testing
  • Lab Testing
  • Trends
  • Market
    • POC Pregnancy and Fertility Test Market
      • Table 7-1: World POC Pregnancy Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
      • Figure 7-1: World POC Pregnancy Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
      • Figure 7-2: World POC Pregnancy Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
      • Figure 7-3: World POC Pregnancy Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
      • Table 7-2: World Lab-Based Fertility Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
      • Figure 7-4: World Lab-Based Fertility Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
      • Figure 7-5: World Lab-Based Fertility Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
      • Figure 7-6: World Lab-Based Fertility Immunoassay Market, Share by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Products
  • TORCH Testing
    • Table 7-3: World Lab-Based TORCH Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 7-7: World Lab-Based TORCH Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 7-8: World Lab-Based TORCH Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 7-9: World Lab-Based TORCH Immunoassay Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Market Participants
    • NowDiagnostics Inc.
    • Salignostics
    • Sekisui
    • Acon
    • Major Companies
    • Abbott
    • Beckman Coulter (Danaher)
    • bioMerieux
    • Church & Dwight
    • Roche
    • Siemens Healthineers

Chapter 8: Pap Smears

  • Introduction
  • Testing for Cervical Cancer
  • Trends
  • Pap Test Market
    • Table 8-1: World IVD Traditional Pap Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 8-1: World IVD Traditional Pap Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 8-2: World IVD Traditional Pap Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 8-3: World IVD Traditional Pap Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • BD (Becton Dickinson)
    • Hologic

Chapter 9: Autoimmune Disease

  • Introduction
  • Genetic Factors
  • Impact on Female Patients
  • Recent Developments
  • Female Autoimmune Lab-Based Immunoassay Market
    • Table 9-1: World Female Lab-Based Autoimmune Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 9-1: World Female Lab-Based Autoimmune Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 9-2: World Female Lab-Based Autoimmune Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World] ($ million)
    • Figure 9-3: World Female Lab-Based Autoimmune Immunoassay Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Bio-Rad
    • Euroimmun (Revvity)
    • Thermo Fisher Scientific

Chapter 10: Bone Density Testing

  • Introduction
  • Alarming Rise in Osteoporosis
  • Propelling the Need for Measurement
  • Trends in DEXA and Competing Technologies
    • DEXA: The Gold Standard
    • Emerging Trends and Accessibility
  • Bone Densitometry Market
    • Table 10-1: World Bone Densitometry for Female Testing Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 10-1: World Bone Densitometry for Female Testing Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 10-2: World Bone Densitometry for Female Testing Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 10-3: World Bone Densitometry for Female Testing Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • DMS Imaging (European Medical Solutions)
    • GE HealthCare
    • Hologic

Chapter 11: Colposcopy

  • Introduction
  • Cervical Cancer Screening and Diagnosis
  • Trends
  • Colposcopy Systems Market
    • Table 11-1: World Colposcopy Systems Market Share, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 11-1: World Colposcopy Systems Market Share, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 11-2: World Colposcopy Systems Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 11-3: World Colposcopy Systems Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Apgar Danmark A/S
    • CooperSurgical
    • Olympus

Chapter 12: Urinary Tract Infections

  • Introduction
  • Leading Cause of Morbidity and Death
  • Impact
  • Trends
  • Technological Advances Outpace Clinical Guidelines
  • Next-Generation Sequencing (NGS)
  • Multiplex PCR, qPCR
  • UTI Molecular Test Market
    • Table 12-1: World Molecular UTI Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 12-1: World Molecular UTI Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 12-2: World Molecular UTI Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 12-3: World Molecular UTI Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Potential in Small Companies
    • Company Highlights
    • BioGX
    • Camtech
    • PathogenDx
    • Randox Laboratories
    • RayBiotech
    • Thermo Fisher Scientific

Chapter 13: Ovarian Cancer

  • Introduction
  • Types of Ovarian Cancer
  • CA-125
  • Trends
  • Multivariate Index Assays and Genomic Tests
  • Ovarian Cancer Biomarker Market
    • Table 13-1: World Ovarian Cancer Biomarkers Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 13-1: World Ovarian Cancer Biomarkers Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
    • Figure 13-2: World Ovarian Cancer Biomarkers Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
    • Figure 13-3: World Ovarian Cancer Biomarkers Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
  • Competitive Landscape
    • Company Highlights
    • Abbott
    • Fujirebio
    • Illumina
    • Roche
    • Thermo Fisher Scientific